Abraxane and Restoril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abraxane (paclitaxel) and Restoril (temazepam). Common drug interactions include osteonecrosis of jaw among females and cystoid macular oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Abraxane and Restoril. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.



On Jul, 07, 2026

22 people who take Abraxane and Restoril together, and have interactions are studied.

Abraxane and Restoril drug interactions.

What are the common drug interactions of Abraxane and Restoril, by gender? *:

female:

  1. Osteonecrosis of jaw (death of bone of jaw)
  2. Chills (felling of cold)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Pain
  5. Diarrhoea
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Injury
  8. Abdominal pain
  9. Arthralgia (joint pain)
  10. Depression

male:

  1. Cystoid macular oedema (fluid accumulation after cataract surgery)
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Hypophysitis (inflammation of the pituitary gland)
  4. Hypotension (abnormally low blood pressure)
  5. Pyrexia (fever)

What are the common drug interactions of Abraxane and Restoril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Abdominal pain
  4. Abscess jaw (tooth abscess or root abscess)
  5. Acute respiratory failure
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Anxiety
  9. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  10. Asthenia (weakness)

50-59:

  1. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  2. Hepatomegaly (abnormal enlargement of the liver)
  3. Nausea (feeling of having an urge to vomit)
  4. Splenomegaly (enlargement of spleen)
  5. Brain neoplasm malignant (brain cancer tumour)
  6. Cervicobrachial syndrome (pain in neck and arm with changing location)
  7. Loss of consciousness
  8. Malignant neoplasm of spinal cord (cancer tumour of spinal cord)
  9. Spinal osteoarthritis (joint cartilage loss in spine)
  10. Atelectasis (partial or complete collapse of the lung)

60+:

  1. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  2. Hypotension (abnormally low blood pressure)
  3. Hair colour changes
  4. Hair disorder
  5. Abscess limb (limb infection)
  6. Anaemia (lack of blood)
  7. Blood creatinine increased
  8. Body temperature increased
  9. Breast inflammation
  10. Breast pain

What are the existing conditions these people have? *

  1. Pain: 4 people, 18.18%
  2. Nausea (feeling of having an urge to vomit): 4 people, 18.18%
  3. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 9.09%
  4. Rashes (redness): 2 people, 9.09%
  5. Pneumonia: 2 people, 9.09%
  6. Nausea And Vomiting: 2 people, 9.09%
  7. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 9.09%
  8. Indigestion: 2 people, 9.09%
  9. Dyspnea (difficult or laboured breathing): 2 people, 9.09%
  10. Diarrhea: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Abraxane and Restoril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abraxane and Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abraxane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abraxane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restoril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel and temazepam (the active ingredients of Abraxane and Restoril, respectively), and Abraxane and Restoril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: